Khorana Score: A Potential New Biomarker for Real Life Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Immunotherapy

被引：0
|
作者：
Bjornhart, B. [1 ]
Hansen, K. [2 ]
Jorgensen, T. [3 ]
Herrstedt, J. [4 ]
Schytte, T. [1 ]
机构：
[1] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
[2] Odense Univ Hosp, Oncol, Odense C, Denmark
[3] Acad Geriatr Canc Res Agecare, Clin Oncol, Odense, Denmark
[4] Zealand Univ Hosp, Clin Oncol, Roskilde, Denmark
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Biomarker; Non small cell lung cancer; Checkpoint inhibitors;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP1.04-29
引用
收藏
页码：S980 / S981
页数：2
相关论文
共 50 条
  • [1] The influence of polypharmacy on outcome in real life non-small cell lung cancer (NSCLC) patients treated with immunotherapy
    Bjoernhart, B.
    Hansen, K. H.
    Jorgensen, T. L.
    Herrstedt, J.
    Schytte, T.
    ANNALS OF ONCOLOGY, 2020, 31 : S858 - S858
  • [2] Immunotherapy in previously treated non-small cell lung cancer (NSCLC)
    Leal, Ticiana A.
    Ramalingam, Suresh S.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S422 - S432
  • [3] Immunotherapy for non-small cell lung cancer (NSCLC)
    Frost, Nikolaj
    Reck, Martin
    INNERE MEDIZIN, 2022, 63 (07): : 709 - 716
  • [4] Pretreatment predictive score for metastatic non-small cell lung cancer patients treated with immunotherapy
    Musaelyan, A.
    Moiseyenko, F.
    Emileva, T.
    Oganesyan, A. P.
    Urtenova, M.
    Odintsova, S.
    Chistyakov, I.
    Akopov, A.
    Orlov, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S77 - S77
  • [5] Fatigue in non-small cell lung cancer (NSCLC) patients treated with immunotherapy, is there a role for physical activity?
    Calman, Lynn
    Rose, Ben
    Cave, Judith
    Evans, Owain
    LUNG CANCER, 2021, 156 : S48 - S48
  • [6] Immunotherapy for Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC). Real-Life Experience from Castile and Leon
    Medina Valdivieso, S.
    Bayona Anton, C.
    Bellido Hernandez, L.
    Lopez-Castro, R.
    Fernandez Gonzalez, M.
    Reyes Garcia, A.
    Diaz Serrano, A.
    Esteban Herrera, B.
    Sanchez Cousido, L.
    Gomez Bravo, R.
    Del Barco, E.
    Cuadrado-Albite, E.
    Vallejo-Pascual, M.
    De Frutos Gonzalez, B.
    Escala Cornejo, R.
    Garcia Pena, T.
    Rojas Piedra, M.
    De La Torre Lazaro, S.
    Escalera Martin, E.
    Diz Tain, P.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S295 - S296
  • [7] Clinical implications of mixed response on prognosis of non-small cell lung cancer (NSCLC) patients treated with Immunotherapy
    Lee, Seyoung
    Um, Taegyu
    Lee, Jeeyeon
    Kim, Peter Haseok
    Yadav, Monica
    Chuchuca, Maria J.
    Chung, Liam Il-Young
    Chae, Young Kwang
    CANCER RESEARCH, 2024, 84 (06)
  • [8] Proteomics score: a potential biomarker for the prediction of prognosis in non-small cell lung cancer
    Peng, Jie
    Zhang, Jing
    Zou, Dan
    Gong, Wuxing
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (05) : 1904 - +
  • [9] Evaluation of combined biomarker in response to immunotherapy (I/O) in patients with advanced non-small cell lung cancer (NSCLC)
    Ramdani, H. O.
    Shatz, S.
    Falk, M.
    Heukamp, L. C.
    Tiemann, M.
    Wesseler, C.
    Schuuring, E.
    Groen, H. J.
    Griesinger, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 153 - 153
  • [10] Nivolumab in Non-Small Cell Lung Cancer (NSCLC): The Real-Life Data
    Dudnik, Elizabeth
    Moskovitz, Mor
    Daher, Sameh
    Shamai, Sivan
    Hanovich, Ekaterina
    Shechtman, Yelena
    Abu-Amna, Mahmoud
    Zer, Alona
    Wollner, Mira
    Bar, Jair
    Merimsky, Ofer
    Cyjon, Arnold
    Shochat, Tzippy
    Peled, Nir
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S417 - S418
12345